Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca2+/calmodulin-dependent protein kinase II

European Journal of Pharmacology

Volumn 465, Issue 1-2, 2003, Pages 199-200

  Wang, Zaijie Jim ^a   Tang, Lei ^a   Xin, Lili ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CaMKII; KN93; Opioid receptor

Indexed keywords

MORPHINE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037470848     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01484-5     Document Type: Article

References (8)

1. Bruggemann I., Schulz S., Wiborny D., Hollt V. Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions. Brain. Res. Mol. Brain Res. 85:2000;239-250.
2. Fan G.H., Wang L.Z., Qiu H.C., Ma L., Pei G. Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 56:1999;39-45.
3. Koch T., Kroslak T., Mayer P., Raulf E., Hollt V. Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J. Neurochem. 69:1997;1767-1770.
4. 2+/calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of alpha and beta isoforms. Mol. Pharmacol. 55:1999;557-563.
5. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:1995;2396-2406.
6. Quillan J.M., Carlson K.W., Song C., Wang D., Sadee W. Differential effects of mu-opioid receptor ligands on Ca(2+) signaling. J. Pharmacol. Exp. Ther. 302:2002;1002-1012.
7. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan T.P. Jr., Ossipov M.H., Lai J., Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 20:2000;7074-7079.
8. Yokota S., Yamamoto M., Moriya T., Akiyama M., Fukunaga K., Miyamoto E., Shibata S. Involvement of calcium-calmodulin protein kinase but not mitogen-activated protein kinase in light-induced phase delays and Per gene expression in the suprachiasmatic nucleus of the hamster. J. Neurochem. 77:2001;618-627.